Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD
Condition: Peripheral Arterial Disease Interventions: Drug: Rivaroxaban; Drug: ASA Sponsors: Poznan University of Medical Sciences; Poznan University of Physical Education; Institute of Human Genetics, Polish Academy of Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Education | Genetics | Intermittent Claudication | Poland Health | Research | Sports Medicine | Universities & Medical Training